SCA
IPXL

Secor Capital Advisors’s Impax Laboratories, Inc. IPXL Stock Holding History

Secor Capital Advisors’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-35,283
Closed -$1.02M – 745
2016
Q2 		$1.02M Buy
+35,283
New +$1.15M 0.13% 240
2014
Q2 		– Sell
-14,224
Closed -$376K – 353
2014
Q1 		$376K Sell
14,224
-3,168
-18% -$79.2K 0.18% 204
2013
Q4 		$437K Buy
+17,392
New +$388K 0.17% 220

Other funds holding IPXL

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Secor Capital Advisors's IPXL Position: Q3 2016 in Review

Secor Capital Advisors sold out of Impax Laboratories, Inc. (IPXL) in Q3 2016, closing a stake of 35,283 shares — an estimated $1.02M sold.

Secor Capital Advisors first reported a position in IPXL in Q4 2013 and held it in 3 quarters. The position peaked at $1.02M in Q2 2016. 196 funds tracked by Wall St. Rank hold IPXL as of Q3 2016.

  • Secor Capital Advisors reported no remaining Impax Laboratories, Inc. position as of Q3 2016 after selling out during the quarter.
  • Secor Capital Advisors sold 35,283 Impax Laboratories, Inc. shares in Q3 2016, an estimated $1.02M.
  • Secor Capital Advisors first reported a position in Impax Laboratories, Inc. in Q4 2013 and held it in 3 quarters.
  • Secor Capital Advisors's Impax Laboratories, Inc. position peaked at $1.02M in Q2 2016.
  • 196 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q3 2016.

Based on Secor Capital Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.